Protective effect of denosumab on bone in older women with primary hyperparathyroidism
Journal of the American Geriatrics Society Jan 30, 2018
Eller-Vainicher C, et al. - Researchers determined the effect of denosumab [used in primary osteoporosis (PO)] in primary hyperparathyroidism (PHPT)-related osteoporosis. In older women with PHPT-related osteoporosis, denosumab therapy was found to be effective.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
